Fredun Pharmaceuticals establishes a new 40,000 sq ft manufacturing facility in Palghar, Maharashtra, marking its fifth production site.
The facility is expected to be operational by October 2026 and will support veterinary products, nutraceuticals, and pharmaceutical formulations.
Company reported FY25 revenues of ₹456 Cr with EBITDA of ₹55 Cr and PAT of ₹21 Cr, serving African, Asian, and Latin American markets.